• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 疫苗接种后发生非典型溶血尿毒综合征:一例报告。

Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report.

机构信息

Clinical Hospital of Botucatu Medical School of São Paulo State University, Professor Mário Rubens Guimarães Montenegro Avenue, Botucatu, Brazil.

Faculty of Medicine of Federal University of Maranhão, Gonçalves Dias Square, São Luís, Brazil.

出版信息

Immun Inflamm Dis. 2024 Jul;12(7):e1270. doi: 10.1002/iid3.1270.

DOI:10.1002/iid3.1270
PMID:38967360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11225072/
Abstract

BACKGROUND

The emergence of new SARS-CoV-2 variants and the global COVID-19 pandemic spurred urgent vaccine development. While common vaccine side effects are well-documented, rare adverse events necessitate post-marketing surveillance. Recent research linked messenger RNA vaccines to thrombotic microangiopathy (TMA), a group of syndromes characterized by microvascular hemolytic anemia and thrombocytopenia. This report describes a new-onset atypical hemolytic-uremic syndrome (aHUS) occurring after COVID-19 vaccination and complements recent literature.

CASE PRESENTATION

A previously healthy 25-year-old woman developed malaise, nausea, edema, and renal dysfunction 60 days postvaccination. Laboratory findings confirmed TMA diagnosis. Genetic testing for complement system mutations was negative. Kidney biopsy supported the diagnosis, and the patient required hemodialysis.

CONCLUSION

This case illustrates the rare occurrence of aHUS following COVID-19 vaccination, with unique characteristics compared to previous reports. Despite the critical role of vaccination in pandemic control, emerging adverse events, such as vaccine-related TMA, must be recognized and investigated. Additional clinical trials are imperative to comprehend the clinical features and pathophysiological mechanisms underlying TMA associated with COVID-19 vaccination.

摘要

背景

新出现的 SARS-CoV-2 变体和全球 COVID-19 大流行促使人们紧急开发疫苗。虽然常见的疫苗副作用已有详细记录,但罕见的不良反应需要进行上市后监测。最近的研究将信使 RNA 疫苗与血栓性微血管病(TMA)联系起来,TMA 是一组以微血管溶血性贫血和血小板减少为特征的综合征。本报告描述了 COVID-19 疫苗接种后新出现的非典型溶血性尿毒综合征(aHUS),并补充了最近的文献。

病例介绍

一位先前健康的 25 岁女性在接种疫苗后 60 天出现不适、恶心、水肿和肾功能不全。实验室检查结果证实了 TMA 的诊断。补体系统基因突变的基因检测为阴性。肾脏活检支持该诊断,患者需要血液透析。

结论

本病例说明了 COVID-19 疫苗接种后罕见发生 aHUS,与以往报告相比具有独特的特征。尽管疫苗在大流行控制中起着至关重要的作用,但必须认识和调查新出现的不良反应,如疫苗相关的 TMA。还需要进行更多的临床试验来了解与 COVID-19 疫苗接种相关的 TMA 的临床特征和病理生理机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/11225072/581f3a75cb3f/IID3-12-e1270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/11225072/581f3a75cb3f/IID3-12-e1270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6450/11225072/581f3a75cb3f/IID3-12-e1270-g002.jpg

相似文献

1
Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report.COVID-19 疫苗接种后发生非典型溶血尿毒综合征:一例报告。
Immun Inflamm Dis. 2024 Jul;12(7):e1270. doi: 10.1002/iid3.1270.
2
Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.mRNA-1273 新冠病毒疫苗加强针接种后发生非典型溶血尿毒综合征:病例报告。
Am J Kidney Dis. 2023 Mar;81(3):364-367. doi: 10.1053/j.ajkd.2022.07.012. Epub 2022 Sep 19.
3
Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.mRNA 疫苗接种引发的非典型溶血尿毒综合征:病例报告。
Front Immunol. 2022 Sep 28;13:1001366. doi: 10.3389/fimmu.2022.1001366. eCollection 2022.
4
Severe pregnancy-associated atypical hemolytic uremia syndrome in the context of the COVID-19 pandemic: a novel survival case report.2019冠状病毒病大流行背景下的严重妊娠相关非典型溶血尿毒综合征:一例新的存活病例报告
BMC Pregnancy Childbirth. 2025 Jan 30;25(1):93. doi: 10.1186/s12884-025-07212-z.
5
COVID-19 vaccination and Atypical hemolytic uremic syndrome.COVID-19 疫苗接种与非典型溶血尿毒综合征。
Front Immunol. 2022 Dec 1;13:1056153. doi: 10.3389/fimmu.2022.1056153. eCollection 2022.
6
A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.妊娠相关性非典型溶血尿毒综合征/补体介导的血栓性微血管病的病例叙述性综述。
Kidney Int. 2024 May;105(5):960-970. doi: 10.1016/j.kint.2023.12.021. Epub 2024 Feb 24.
7
New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.接种 COVID-19 疫苗后的新发和复发血栓性微血管病。
J Med Virol. 2023 Jul;95(7):e28946. doi: 10.1002/jmv.28946.
8
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.非典型溶血尿毒综合征患者孤立性小肠血栓性微血管病 - 病例报告。
BMC Nephrol. 2020 Mar 24;21(1):104. doi: 10.1186/s12882-020-01766-0.
9
Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.病例系列:2019 年冠状病毒病感染作为非典型溶血尿毒症综合征的诱因:两例报告。
J Med Case Rep. 2021 Dec 13;15(1):587. doi: 10.1186/s13256-021-03144-2.
10
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision.患者患有显微镜下多血管炎和非典型溶血尿毒综合征,在接种第三剂抗 SARS-CoV2 疫苗 mRNA-1273 后 3 周进入终末期肾病:病例报告并文献复习。
Medicine (Baltimore). 2023 Dec 15;102(50):e36560. doi: 10.1097/MD.0000000000036560.

本文引用的文献

1
New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.接种 COVID-19 疫苗后的新发和复发血栓性微血管病。
J Med Virol. 2023 Jul;95(7):e28946. doi: 10.1002/jmv.28946.
2
Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination.与新型冠状病毒肺炎(COVID-19)或严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种相关的补体介导的血栓性微血管病
Kidney Int Rep. 2023 May 22;8(8):1506-13. doi: 10.1016/j.ekir.2023.05.010.
3
End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report.
接种阿斯利康新冠疫苗后出现非典型溶血性尿毒症综合征导致的终末期肾病:一例报告
Vaccines (Basel). 2023 Mar 16;11(3):679. doi: 10.3390/vaccines11030679.
4
COVID-19 vaccination and Atypical hemolytic uremic syndrome.COVID-19 疫苗接种与非典型溶血尿毒综合征。
Front Immunol. 2022 Dec 1;13:1056153. doi: 10.3389/fimmu.2022.1056153. eCollection 2022.
5
Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.mRNA-1273 新冠病毒疫苗加强针接种后发生非典型溶血尿毒综合征:病例报告。
Am J Kidney Dis. 2023 Mar;81(3):364-367. doi: 10.1053/j.ajkd.2022.07.012. Epub 2022 Sep 19.
6
Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.mRNA 疫苗接种引发的非典型溶血尿毒综合征:病例报告。
Front Immunol. 2022 Sep 28;13:1001366. doi: 10.3389/fimmu.2022.1001366. eCollection 2022.
7
First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2.接种BNT162b2新冠疫苗后出现非典型溶血性尿毒症综合征的首例病例。
Clin Kidney J. 2022 Apr 12;15(7):1429-1430. doi: 10.1093/ckj/sfac098. eCollection 2022 Jul.
8
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后免疫介导的血栓性血小板减少性紫癜
Blood. 2022 Apr 21;139(16):2565-2569. doi: 10.1182/blood.2021015149.
9
New-Onset Kidney Diseases after COVID-19 Vaccination: A Case Series.新冠疫苗接种后新发肾脏疾病:病例系列
Vaccines (Basel). 2022 Feb 16;10(2):302. doi: 10.3390/vaccines10020302.
10
Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine.由mRNA新冠疫苗引发的灾难性抗磷脂综合征
Clin Exp Rheumatol. 2022 May;40(5):1054-1055. doi: 10.55563/clinexprheumatol/s3sbgu. Epub 2021 Dec 7.